The impact of glucosamine on age-related macular degeneration in patients: A nationwide, population-based cohort study

ConclusionsGlcN treatment can decrease the risk of developing dry type AMD. Further prospective controlled studies are needed to determine the effectiveness of GlcN treatment in patients with AMD and the associated mechanism.
Source: PLoS One - Category: Biomedical Science Authors: Source Type: research